Recent Updates
Recently added Catalysts
SANA Negative Sentiment Score: 25/100

Sana Biotechnology, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. May 20, 2025 Deadline to file Lead Plaintiff Motion.

Key Takeaway: The Portnoy Law Firm has announced a class action on behalf of investors in Sana Biotechnology, Inc. who purchased securities between March 17, 2023, and November 4, 2024. Investors have until May 20, 2025, to file a lead plaintiff motion. The lawsuit alleges that Sana's management made materially false statements about the company's financial health and product development, which misled investors about the company's prospects. Specific issues cited include a lack of sufficient capital and the potential discontinuation of some product candidates.

Market Sentiment Analysis

CONCERNS & RISKS

  • Investors may have lost money due to misrepresentations by the company's management.
  • Sana is reported to be at risk of lacking sufficient capital to sustain its operations.
  • There are allegations that the company's product development programs are less promising than previously suggested.
  • Potential workforce reductions and discontinuation of certain programs may further harm investor confidence.

Full Press Release Details

Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, April 16, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Sana Biotechnology, Inc. ("Sana" or the "Company") (NASDAQ: SANA) investors of a class action representing investors that bought securities between March 17, 2023 to November 4, 2024, inclusive (the "Class Period"). SANA investors have until May 20, 2025 to file a lead plaintiff motion.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
The complaint alleges that, during the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Sana was at significant risk of lacking sufficient capital to sustain its current operations and continue development of one or more of its product candidates; (ii) the Company’s programs—SC291 in oncology, SC379, and SG299—were less promising than Defendants had represented to investors; (iii) to conserve cash and prioritize its more promising pipeline assets, Sana was likely to reduce funding for, or discontinue, SC291 in oncology, SC379, and SG299, and significantly cut its workforce; (iv) as a result, Defendants overstated the Company’s financial ability to maintain its operations and advance its product pipeline; and (v) consequently, Defendants’ public statements were materially false and/or misleading throughout the Class Period.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
Attorney Advertising

Tags

Frequently Asked Questions

What is the deadline for SANA investors to file claims?

SANA investors must file their lead plaintiff motion by May 20, 2025.

How can investors contact the Portnoy Law Firm?

Investors can reach attorney Lesley F. Portnoy at 310-692-8883 or lesley@portnoylaw.com.

What is the class action period for SANA securities?

The class action period for SANA securities is from March 17, 2023, to November 4, 2024.

Is there a cost for the case evaluation?

Yes, the Portnoy Law Firm offers a complimentary case evaluation for investors.

What was alleged against Sana during the class period?

Sana allegedly made false statements about its financial stability and product development.

Last updated: Apr 16, 2025